“Causal” and the Study of Viral Infections in Alzheimer’s
Maria Jesus Bullido, a professor at the Autonomous University and researcher at the CSIC’s Severo Ochoa Molecular Biology Center, has dedicated 25 years to studying the potential role of viral infections, particularly herpesvirus 1, in the development of Alzheimer’s disease. This hypothesis, which has been met with skepticism, has recently gained renewed attention.
The Herpes Zoster Vaccine and the Viral Origin of Alzheimer’s
Bullido acknowledges the need for caution when discussing the cause-effect relationship between viruses and Alzheimer’s. However, she believes that microorganisms, including viruses, hold significant insights into understanding this modern epidemic.
Evaluating the Recent Study on Herpes Zoster Vaccine
Bullido comments on a recent study that associates the herpes zoster vaccine with a lower incidence of Alzheimer’s. While she acknowledges the study’s strong epidemiological content, she emphasizes that it is not yet peer-reviewed.
The study builds upon previous research conducted on the same population in Wales. However, it takes a different approach by focusing on the time when the shingles vaccine was introduced, leading to a slightly stronger conclusion.
The Evidence and the Use of the Word “Causal”
Bullido finds the evidence compelling, indicating a significant decrease in new cases of dementia. However, she is cautious about using the word “causal” as the authors of the study do. Nevertheless, she finds the relationship between viral infections and Alzheimer’s intriguing and worthy of further investigation.
The Infectious Origin of Alzheimer’s
Bullido acknowledges that the infectious hypothesis of Alzheimer’s has been considered controversial in the past. While she believes that viruses can play a role in the disease, she does not claim that all cases of dementia are caused by infections. She emphasizes the complexity of the disease and suggests that it may have multiple origins.
The Role of Viruses and the Potential for a Vaccine
Bullido suggests that viruses can be participants in the development of Alzheimer’s, and in some cases, they may act as triggers. While she does not believe that preventing infections will entirely prevent Alzheimer’s, she believes that it can help mitigate the progression of the disease.
The Possibility of a Vaccine for Alzheimer’s
Bullido believes that a vaccine could be developed for certain cases of Alzheimer’s. However, she notes that the viruses involved in these diseases are often latent, making it challenging to create a vaccine against them.
The Importance of Vaccinating Children
Bullido suggests that vaccinating children against viruses like herpes simplex and zoster could be beneficial in the long term. By preventing initial infections, the occurrence of dementia in later years could potentially be reduced.
Vaccination for Those Already Infected
For individuals already infected with latent viruses, such as herpes simplex and zoster, there are currently no vaccines available to prevent reactivation. However, the shingles vaccine has shown promise in preventing reactivation in older individuals.
The Effectiveness of Vaccines and Future Implications
Bullido believes that vaccinating the elderly against herpes zoster could be worthwhile, as it may delay the onset of dementia. She suggests that vaccines, despite not providing complete protection against Alzheimer’s, can have a significant impact on public health.
A Potential Natural Experiment
Bullido highlights the possibility of observing a decrease in Alzheimer’s cases among vaccinated children compared to previous generations. However, she acknowledges the need to account for confounding factors, such as changes in socioeconomic status and overall infection rates.
Exploring the Link between Antiviral Drugs and Dementia
Bullido mentions studies that suggest a lower incidence of dementia among individuals treated with antiviral drugs like acyclovir. While these findings are promising, she emphasizes the need for further research to establish a causal relationship.
Seeking a Causal Relationship
Bullido acknowledges the challenges in establishing a causal relationship between the herpes virus and dementia. However, she remains committed to exploring the potential role of viral infections in Alzheimer’s.
A Possible Link Between Herpes Simplex and Alzheimer’s: Unraveling the Mystery
Investigating the Causal Relationship
When discussing the connection between herpes simplex and Alzheimer’s, it is important to consider a direct relationship rather than a mere correlation. In 1998, Ruth Itzhaki, a prominent figure in the infectious hypothesis, presented compelling evidence that individuals with herpes simplex and the APOE4 allele face a significantly higher risk of developing Alzheimer’s.
Unraveling the Hypothesis: 25 Years of Research
My journey into this field began when my boss challenged me to dismantle the hypothesis that a virus in the brain would have no impact. Over the course of 25 years, we conducted numerous experiments at various levels, from studying genes associated with the herpes viral cycle to infecting cells and mice. Despite our efforts, we have been unable to rule out the link between herpes simplex and Alzheimer’s.
Experimental Evidence: Accumulations and Infections
Our research led us to explore whether the presence of the herpes simplex virus triggers the formation of amyloid plaques and neurofibrillary tangles, the hallmarks of Alzheimer’s. Through infecting cells, we observed the appearance of these accumulations. Furthermore, when we infected mice, we discovered that the virus had a greater impact on the brain if the mice had the Alzheimer’s risk genotype. These experiments provided further support for the potential connection between herpes simplex and Alzheimer’s.
The Challenge of Proving Causality
Proving a causal relationship between viruses and degenerative diseases, such as Alzheimer’s, is no easy task. The traditional postulates set by Robert Koch, which require demonstrating the presence of a virus in all patients with the disease, do not align with these complex and long-term connections. This challenge is not unique to herpes simplex and Alzheimer’s but extends to other emerging connections, including multiple sclerosis and Epstein-Barr.
Expanding Our Perspective: Integrating Epidemiological and Experimental Evidence
While experimental evidence continues to accumulate, there is a need for more epidemiological studies to support the connection between viruses and degenerative diseases. It is crucial to conduct directed clinical trials to explore potential treatments. For instance, Ruth Itzhaki has initiated a clinical trial involving acyclovir, a drug used to treat herpes simplex, to investigate its impact on Alzheimer’s.
Unlocking New Possibilities: Viruses as Targets for Treatment
The potential role of viruses in the onset of Alzheimer’s opens up new avenues for treatment. Neurologists believe that the treatment for Alzheimer’s will likely involve multiple approaches rather than a single solution. Inflammation, which can be triggered by viral infections, has gained significant attention as a potential target for intervention. While inflammation serves as a protective response, excessive inflammation can lead to damage.
The Puzzle of Dementia: Genetics, Lifestyle, and Infections
Genetics, lifestyle factors, and infections are interconnected pieces of the dementia puzzle. Recent European epidemiological studies have highlighted the importance of controlling hypertension, engaging in physical activity, and maintaining social relationships to delay the onset of dementia. Interestingly, different stages of life require different approaches, with physical health being crucial for young adults and social activity playing a significant role in older individuals. Additionally, addressing hearing loss can have a positive impact on reducing the risk of dementia.
The Complex Role of Genetics
Genes play a significant role in the body’s response to infections, and their interaction with other factors is essential. While certain genetic mutations, such as the presenilin gene mutation, guarantee the development of Alzheimer’s, they are rare. Most cases involve genetic susceptibility, with the APOE4 gene being a prominent risk factor. However, the effect of individual genes is minimal, and it is the collective impact of multiple genes that contributes to the overall susceptibility to Alzheimer’s.
The Limitations of Genetic Susceptibility Testing
While genetic susceptibility testing, particularly for the APOE4 variant, can provide valuable insights, it should not be a cause for alarm. The focus on genetics in recent decades has overshadowed other avenues of research, such as infections and inflammation. For individuals with the APOE4 variant, there are currently no effective treatments available, making the practical utility of this knowledge limited. Genetic testing for presenilin genes is more relevant for early-onset and aggressive cases, primarily for genetic counseling purposes.
The Impact of COVID-19 on Research
The ongoing COVID-19 pandemic has sparked renewed interest in exploring the relationship between infections and neurological diseases. The persistence of COVID-19 has highlighted the need to understand the long-term consequences of viral infections. This has prompted researchers to delve deeper into the potential links between infections and conditions like Alzheimer’s.
Exploring the Impact of Covid on Virus Research
Indeed, the persistent Covid has left its mark, shedding light on the significance of viruses and fueling extensive research in the field. The long-term consequences of this pandemic are yet to be fully understood, but its influence on scientific exploration is undeniable.
Increased Interest and Funding in Virus Research
Has there been a surge in interest or funding for projects similar to yours? In terms of financing, not particularly. However, the field of virus research has experienced a remarkable surge in attention. In the realm of Alzheimer’s, the infectious hypothesis was once considered highly unorthodox and faced severe criticism. I personally witnessed these attacks in the early 2000s. Fortunately, perspectives have shifted, and this change is undoubtedly positive.
The Financial Landscape of Virus Research
While financing for our specific project has not significantly increased, I do believe that, in general, the field of virus research is now receiving more financial support. However, public funding in Spain, as is often the case, remains limited. This is not a complaint, but a reality. Resources are scarce, and investment in one area often means diverting funds from another. The question then arises, where do we make these necessary trade-offs?
Follow the topics that interest you